A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles. The team has developed the so-called “upconverting” nanoparticles that not only convert infrared light into UV-visible light, but also are water-soluble, remain stable in complex […]Continue Reading ...
Credit: Australian National University Australian researchers have developed ground-breaking new technology which could prove crucial in treating brain injuries and have multiple other applications, including testing the success of cancer therapies. Associate Professor David Nisbet from The Australian National University (ANU) and Dr. Richard Williams from RMIT have developed a 3-D tool to model brain […]Continue Reading ...
Scanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIH A new discovery by an international research team—co-led by UBC Canada 150 Research Chair Josef Penninger and Harvard Medical School neurobiologist Clifford Woolf—could have implications for therapies for cancer and autoimmune diseases. In a study published today in Nature, researchers outline a new […]Continue Reading ...
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa” Foundation. The results also indicated that early exposure to the parasite does not affect the risk […]Continue Reading ...
WEDNESDAY, Nov. 14, 2018 — For the billions of young people who seek community and connection on social media, new research warns their search may be in vain. Instead, spending too much time on Facebook, Snapchat and Instagram may actually increase the risk of depression and loneliness. So concludes a small analysis that tracked the […]Continue Reading ...
During the holiday season, it can be difficult for even the most determined of us to stick to a healthy diet. A piece of Halloween candy here, a pumpkin spice latte there, and suddenly we’re left feeling like we forgot what vegetables taste like. Our weight isn’t the only aspect of our health that can […]Continue Reading ...
HIV-1 Virus. Credit: J Roberto Trujillo/Wikipedia In a proof-of-principle study, researchers at Johns Hopkins report that a certain liver immune cell called a macrophage contains only defective or inert HIV-1 copies, and aren’t likely to restart infection on their own in HIV-1-infected people on long-term antiretroviral therapy (ART). The study, the investigators say, strongly suggest […]Continue Reading ...
Credit: Mary Ann Liebert, Inc., publishers Diagnosis of HIV-1 infection in the 4-year old child of an HIV-negative mother led to a forensic analysis to determine the source of the infection and try to date the transmission of the virus. The results of genetic, phylogenetic, and serologic data analysis on both the father and son […]Continue Reading ...
WEDNESDAY, Nov. 14, 2018 — A pharmacist-led intervention has the potential to reduce prescriptions for inappropriate medication in older adults, according to a study published in the Nov. 13 issue of the Journal of the American Medical Association. Philippe Martin, Ph.D., from the University of Montreal, and colleagues compared the effectiveness of a consumer-targeted, pharmacist-led […]Continue Reading ...
Nov 13 2018 Cardiovascular disease is the leading cause of death and a major cause of heart attacks, strokes and disability for people living with type 2 diabetes – only half recognize their risk The American Heart Association (AHA) and the American Diabetes Association (ADA) today launched their new, multi-year awareness and education initiative, Know […]Continue Reading ...
A new pharmacological agent demonstrates promising results for the prevention of a wide range of heart rhythm disorders, including both cardiac and brain injury-induced arrhythmias. Furthermore, the compound (SS-68) demonstrates significant activity in conditions of reduced blood flow to the heart caused by obstructed arteries. The study, conducted by a research team led by Dr […]Continue Reading ...
Credit: CC0 Public Domain Scientists have made a major discovery that shines a new, explanatory light on the link between obesity and cancer. Their research confirms why the body’s immune surveillance systems—led by cancer-fighting Natural Killer cells—stutter and fail in the presence of excess fat. Additionally, it outlines possible paths to new treatment strategies that […]Continue Reading ...
Maidenhead, UK. – 16 November, 2018 – Biogen was announced as the winner of the Orphan Product Award at last night’s UK Prix Galien 2018, for Spinraza®, which in 2017 became the first and only approved treatment for 5q spinal muscular atrophy (SMA). This is further recognition of the innovative science behind the development of […]Continue Reading ...
Nov 16 2018 In optogenetics, researchers use light to control protein activity. This technique allows them to alter the shape of embryonic tissue and to inhibit the development of abnormalities. Now, scientists in EMBL’s De Renzis group have enhanced the technique to stop organ-shaping processes in fruit fly embryos. Their results, published in The EMBO […]Continue Reading ...
FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea November 16, 2018 — The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool. “Travelers’ diarrhea […]Continue Reading ...
- Scientists succeed in increasing stability, biocompatibility of light-transducing nanoparticles
- Sugar, a ‘sweet’ tool to understand brain injuries
- Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults
- Novel discovery could lead to new cancer, autoimmune disease therapy
- AHA and ADA launch new initiative to help people with type 2 diabetes reduce heart disease risk
- Balanced production of pro and anti-inflammatory cytokines at two years of age protects against malaria
- New pharmacological agent shows promise for prevention of heart rhythm disorders
- All That Social Media May Boost Loneliness, Not Banish It
- Scientists shine new light on link between obesity and cancer
- Risk factors for cardiovascular disease closely track with changes in diet patterns
- Biogen Scoops Sixth Prix Galien Award with UK Win for Life-Changing Rare Disease Medicine
- Detectable HIV-1 in treated human liver cells found to be inert
- Using light to control crucial step in embryonic development
- Unusual case of father-to-son HIV transmission reported
- FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
- Poverty blamed on widening north-south gap in young adult deaths in England
- Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows
- Consensus Statement Issued on Management of Foot, Ankle Gout
- Fine particle air pollution is a public health emergency hiding in plain sight
- In-hospital mortality higher among patients with drug-resistant infections